Tarsus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TARS for the last quarter is 13.08 M USD, and it's 598.88% higher compared to the previous quarter. The net income of Q4 23 is -41.90 M USD.